Bulfinch Acquires Additional Harvard Square Asset for Potential Life Sciences, Medical or Office Use

0
348

Cambridge, MA – The Bulfinch Companies, Inc., a private, real estate investment, development and management firm, announces an affiliate of the company has  acquired 1120 Massachusetts Avenue, a 7,200 SF building located in the heart of Harvard Square.

The acquisition represents Bulfinch’s 13th property in the booming technology, life science and biotech hub of Cambridge, MA. Bulfinch plans to redevelop and reposition the asset as a first-class office, medical or biotech property, complete with a roof deck. The building has two stories above grade and one below, with floortoceiling windows on the street providing high visibility and ample daylighting. Ideally situated a short walk from Boston’s “Brain Train” at the Harvard Square Red Line T stop, the property is just steps away from a variety of shops, restaurants and vibrant business centers at Harvard Square and Central Square.

This acquisition further strengthens Bulfinch’s portfolio in the Cambridge market. Earlier this year, Bulfinch announced the completion of its new 280,000 SF lab building at Cambridge Discovery Park, located in the Alewife Life Science Cluster, just 10 minutes’ drive from 1120 Massachusetts Avenue. Bulfinch is also the manager of Osborn Triangle, a three-property life science and biotech development in Cambridge’s Kendall Square neighborhood, boasting tenants Lab Central, Pfizer and Novartis, as well as numerous additional buildings in Cambridge.

“Cambridge is the global epicenter of life science, technology and medical research, and Bulfinch has committed to expanding our portfolio in this space,” said Eric Schlager, CEO of Bulfinch. “During this crucial time of combatting a global pandemic, we’re meeting the need for lab space among key researchers in biodiscovery. Not only does the presence of life science research enrich the Cambridge culture, it also positions the city as a strong investment location, as life science and biotechnology discoveries become increasingly imperative.”

The acquisition of 1120 Massachusetts Avenue represents a continued commitment to Bulfinch’s mission, Discover + Deliver, as the company works with passion, creativity and collaboration with tenants and investors to create exceptional workplaces.